| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Net cash provided by (used in) financing activities | 95 | 50 |
| Effect of exchange rates on cash | -391 | -235 |
| Net change in cash and cash equivalents | -6,606 | -2,440 |
| Cash and cash equivalents at beginning of period | 31,741 | - |
| Cash and cash equivalents at end of period | 25,135 | - |
Apyx Medical Corp (APYX)
Apyx Medical Corp (APYX)